These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11775935)

  • 1. Protease inhibitors in children: combination therapy reduced death by two thirds.
    James JS
    AIDS Treat News; 2001 Nov; (374):4-5. PubMed ID: 11775935
    [No Abstract]   [Full Text] [Related]  

  • 2. Improved AIDS treatments bring life and hope--at a cost.
    Brink S
    US News World Rep; 2001 Jan; 130(4):44-6. PubMed ID: 11211336
    [No Abstract]   [Full Text] [Related]  

  • 3. HIV's potent cocktail.
    Lusky K
    Contemp Longterm Care; 1999 Dec; 22(12):59. PubMed ID: 10977335
    [No Abstract]   [Full Text] [Related]  

  • 4. Recent developments in antiretroviral therapy.
    DeSimone GA
    Clin J Oncol Nurs; 2001; 5(6):266, 275. PubMed ID: 11899628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A French lesson. French experience shows full funding of treatment advances saves money.
    Alcorn K
    J Int Assoc Physicians AIDS Care; 1997 Apr; 3(4):49. PubMed ID: 11364203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How HIV drugs work 101.
    Pietrandoni G
    Posit Aware; 2001; 12(5):26-7. PubMed ID: 11688481
    [No Abstract]   [Full Text] [Related]  

  • 7. Rescue regimens: the value of protease-inhibitor boosting.
    Segal-Maurer S; Schütz M
    Body Posit; 2001 Sep; 14(9):11-3. PubMed ID: 11693112
    [No Abstract]   [Full Text] [Related]  

  • 8. The end of AIDS?
    Leland J
    Newsweek; 1996 Dec; 128(23):64-8, 71, 73. PubMed ID: 10162943
    [No Abstract]   [Full Text] [Related]  

  • 9. Consider these initial combination regimens.
    AIDS Alert; 2010 Apr; 25(4):40. PubMed ID: 20556895
    [No Abstract]   [Full Text] [Related]  

  • 10. The ever-changing HIV treatment landscape.
    Berger DS
    Posit Aware; 2003; 14(1):69-70, 76. PubMed ID: 12630378
    [No Abstract]   [Full Text] [Related]  

  • 11. ABC in the news.
    Carter M
    IAPAC Mon; 2006 Jun; 12(6):178-9. PubMed ID: 17233104
    [No Abstract]   [Full Text] [Related]  

  • 12. Protease inhibitors: opium of the masses?
    Martinez LJ
    Res Initiat Treat Action; 2000 Sep; 6(3):7-11. PubMed ID: 11708167
    [No Abstract]   [Full Text] [Related]  

  • 13. Teaching adherence to substance users.
    TreatmentUpdate; 2002; 14(4):4-5. PubMed ID: 12064315
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-HIV agents. Atazanavir as a booster for protease inhibitors.
    TreatmentUpdate; 2003; 15(4):1-2. PubMed ID: 17216850
    [No Abstract]   [Full Text] [Related]  

  • 15. New versions of antiretroviral guidelines contain some important changes.
    Murphy MJ
    Fac Notes (New Orleans La); 1999; 11(4):1-3. PubMed ID: 11810843
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-HIV agents. Saquinavir--switching from Fortovase to Invirase.
    TreatmentUpdate; 2004; 16(3):8-9. PubMed ID: 17219608
    [No Abstract]   [Full Text] [Related]  

  • 17. HIV integrase inhibitors show potent activity in clinical trials.
    Winslow DL
    AIDS Alert; 2007 Jan; 22(1):10-1. PubMed ID: 17722343
    [No Abstract]   [Full Text] [Related]  

  • 18. The current role of ritonavir-boosted protease inhibitors in the management of HIV infection.
    Wilkins E
    J HIV Ther; 2008 Mar; 13(1):9-18. PubMed ID: 18953268
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-HIV agents. Atazanavir and saquinavir.
    TreatmentUpdate; 2004; 16(3):9-10. PubMed ID: 17219610
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-HIV drug update.
    Proj Inf Perspect; 2000 Mar; (29):6-7. PubMed ID: 12769050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.